Soft Tissue Infection
📧 Sign up to get email alerts when something new happens for Soft Tissue Infection.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-01-20EMA Authorised: Daptomycin Hospira (daptomycin) — Pfizer Europe MA EEIG
The EMA authorised Daptomycin Hospira (daptomycin) for marketing in the EU for soft tissue infections and bacterial skin infections, with de…
-
EMA approval · 2025-11-14EMA Authorised: Zavicefta (avibactam sodium;ceftazidime pentahydrate) — Pfizer Ireland Pharmaceuticals Unlimited Company
The EMA authorised Zavicefta (avibactam sodium and ceftazidime pentahydrate) for treatment of pneumonia, soft tissue infections, urinary tra…
-
EMA approval · 2025-11-07EMA Authorised: Cubicin (daptomycin)
The European Medicines Agency authorised Cubicin (daptomycin) for Gram-positive bacterial infections including bacteremia, soft tissue infec…
-
EMA approval · 2024-11-20EMA Authorised: Tenkasi (previously Orbactiv) (oritavancin (diphosphate)) — Menarini International Operations Luxembourg S.A.
The European Medicines Agency has authorised Tenkasi (oritavancin diphosphate) by Menarini International Operations Luxembourg S.A. for soft…